Abstract: A method of purifying lunasin or a lunasin-containing complex produced in a plant includes providing a plant material from the plant, and isolating the lunasin-containing complex from the plant material, and/or releasing lunasin from the lunasin-containing complex. A composition for treating a cancer or an inflammation-related disease in a subject includes a lunasin-containing complex. A composition for treating a cancer or an inflammation-related disease in a subject includes a lunasin polypeptide and/or a lunasin-containing complex; and curcumin, wherein the combination of the a lunasin polypeptide or lunasin-containing complex and the curcumin has a synergistic effect. A method for treating a cancer or an inflammation-related disease includes administering a composition including a lunasin-containing complex, or a lunasin polypeptide and/or a lunasin-containing complex, and curcumin.

Abstract: In some embodiments a differential communication channel compensates for electrostatic discharge capacitance of an electrostatic discharge component by increasing an impedance of the differential communication channel near the electrostatic discharge component. Other embodiments are described and claimed.

Abstract: A disposable blood sampling device is disclosed herein, which includes a plunger, a rubber stopper, a barrel, a sealing member, a needle holder, a protection sleeve, an anticoagulant storing tube and a needle sheath. In use, the disposable blood sampling device is deconstructed by removing each component therefrom and is unable to be assembled again for recycling. Furthermore, the needle can be hidden in the protection sleeve before it is detached from the blood sampling device, which effectively prevents a medical operator from being hurt or even infected by the needle.

Abstract: A disposable blood sampling device is disclosed herein, which includes a plunger, a rubber stopper, a barrel, a sealing member, a needle holder, a protection sleeve, an anticoagulant storing tube and a needle sheath. In use, the disposable blood sampling device is deconstructed by removing each component therefrom and is unable to be assembled again for recycling. Furthermore, the needle can be hidden in the protection sleeve before it is detached from the blood sampling device, which effectively prevents a medical operator from being hurt or even infected by the needle.

Abstract: Techniques are provided for controlling data access to maintain data integrity. A request is received to perform an action on a data element. The request is analyzed based on at least one data access rule associated with the data element. This analysis further utilizes a data structure model associated with the data element. The request is approved if the request satisfies the data access rule. The request is rejected if the request does not satisfy the data access rule.

Abstract: A method including: sonicating a stream containing a dispersion comprised of agglomerated primary particles; and filtering the resulting sonicated stream containing a dispersion comprised of de-agglomerated primary particles. An apparatus including: an ultrasonic adapter to ultrasonicate a stream of a liquid dispersion of agglomerated primary particles; and a filter member adapted to filter the resulting ultrasonicated stream containing a dispersion of de-agglomerated primary particles; and optionally a coater adapted to coat the resulting filtered stream containing a dispersion of de-agglomerated primary particles onto a receiver.

Abstract: A method for automating web access captures web requests submitted by a user on a client to a web server. The web requests are filtered and stored on the web server. The filtered web requests are recorded in a log file on the web server. The log file is sent to the client. The client submits the filtered web requests from the log file to the web server. The web responses in response to the submitted filtered web requests are received and stored on the client as a reference file.

Abstract: Techniques are provided for controlling data access to maintain data integrity. A request is received to perform an action on a data element. The request is analyzed based on at least one data access rule associated with the data element. This analysis further utilizes a data structure model associated with the data element. The request is approved if the request satisfies the data access rule. The request is rejected if the request does not satisfy the data access rule.

Abstract: A method for improving the quality of a dip coated layer that is deposited by flowing a solution along a substrate in a gap between the substrate and a wall, including: (a) determining a yield stress, a viscosity, a density, and a surface tension of the solution, and selecting a wet thickness of the coated layer; (b) determining a coating speed based on the determined viscosity, the determined density, the determined surface tension of the solution, and the selected wet layer thickness; and (c) selecting a distance for the gap and calculating the shear stress of the solution in the gap based on the gap distance, wherein the shear stress is greater than the yield stress.

Abstract: A method of forming one or more polymer containing layers on a substrate using ink jet nozzles. The method is particularly suited to forming one or more polymer containing layers of a photoreceptor. The polymer containing layers may be formed by moving a substrate, in particular a cylindrical substrate, past the ink jet nozzles, by moving the ink jet nozzles over the substrate, or both. The ink jet nozzles are capable of being independently controlled in order to permit precise location of the coating on the substrate.

Abstract: A coating process for the fabrication of organic photoreceptors employs an electrically conductive single slot die biased to allow an electric field between the die and the ground plane on the photoreceptor substrate. The homogenous coating dispersion is fed through the die at a predetermined gap and rate to control coating thickness at the same time that an electric field is applied. The formulation, rheology, particle mobility, coating speed, electric field and the like are controlled so that the photogenerator particles migrate to the substrate in the dwell time defined by the coating die region.

Abstract: A manufacturing system including: (a) a vessel for holding a liquid; (b) a first member and a second member, each having a flat surface, wherein the flat surface of the first member faces and is spaced from the flat surface of the second member, thereby defining a gap region between the two flat surfaces, wherein a section of the first member is transparent through the thickness of the first member; (c) a liquid delivery system connected to the vessel and the gap region which delivers the liquid to the gap region and the liquid flows in the gap region in view of the transparent section of the first member; (d) a camera positioned to view through the transparent section of the first member; (e) image processing means coupled to the camera for determining the homogeneity of the liquid in the gap region; and (f) liquid dispensing equipment connected to the liquid delivery system.

Abstract: A coating process includingproviding a coating composition comprising finely divided photoconductive organic particles dispersed in a solution of a film forming binder, the composition having a predetermined substantially constant liquid yield stress value,flowing the composition along a feed channel,introducing the composition into an elongated manifold cavity comprising a least a first progressively narrowing channel extending away from the feed channel,flowing the coating composition along at least the first progressively narrowing channel,flowing the coating composition out of the manifold cavity into an extrusion passageway extending away from at least the first progressively narrowing channel,shaping the coating composition into a thin ribbon shaped stream in the extrusion passageway,depositing the ribbon shaped stream on a substrate to form a coating, andmaintaining an applied shear stress to the composition that is greater than the yield shear stress value of the coating composition while flowing the

Abstract: The present invention provides for the use of Tripterygium wilfordii Hook F extracts and purified components thereof in the treatment of inflammation or an immune disorder with concomitant lack of steroidal effect. Extracts of this plant (T2) bound to the glucocorticoid receptor and competitively inhibited glucocorticoid mediated cellular processes, such as dexamethasone binding to the glucocorticoid receptor, glucocorticoid mediated activation of target genes, dexamethasone dependent cellular growth, with concomitant inhibition of cyclooxygenase-2 induction and inflammatory processes such as the production of prostaglandin E.sub.2. The T2 extract components triptolide and tripdiolide were effective inhibitors. The particular advantage provided by the methods herein is the treatment or prevention of inflammation and the concomitant lack of steroidal agonist effects and NSAID side effects. Conditions treatable by the present methods include inflammation and immune disorders including autoimmune disease.

Abstract: The present invention provides for the use of Tripterygium wilfordii Hook F extracts and purified components thereof in the treatment of inflammation or an immune disorder with concomitant lack of steroidal effect. Extracts of this plant (T2) bound to the glucocorticoid receptor and competitively inhibited glucocorticoid mediated cellular processes, such as dexamethasone binding to the glucocorticoid receptor, glucocorticoid mediated activation of target genes, dexamethasone dependent cellular growth, with concomitant inhibition of cyclooxygenase-2 induction and inflammatory processes such as the production of prostaglandin E.sub.2. The T2 extract components triptolide and tripdiolide were effective inhibitors. The particular advantage provided by the methods herein is the treatment or prevention of inflammation and the concomitant lack of steroidal agonist effects and NSAID side effects. Conditions treatable by the present methods include inflammation and immune disorders including autoimmune disease.

Abstract: A Tripterygium wilfordii Hook F preparation having an improved LD.sub.50 in mice, an improved therapeutic activity:toxic index ratio and a lower amount of triptolide as compared to previous preparations is disclosed. The LD.sub.50 in mice of the T. wilfordii preparation is greater than about 860 mg/kg, the therapeutic activity:toxic index ratio is greater than about 2.6.times.10.sup.-3, and the amount of triptolide is less than about 1.3 .mu.g/mg. The preparation is useful for immunosuppression, in particular, the suppression of primary antibody response and suppression of autoimmune disease and for the treatment of rheumatoid arthritis.